2.38 USD
↗ 0.04 (1.93%)AT CLOSE (11:59 AM EDT)
Connect Biopharma Holdings Limited Ordinary Shares
CNTBNASDAQ • USD
2.38
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.38
↗ 0.00 (0.00%)
Market: CLOSED
Shares of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) are trading at $2.38. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, CNTB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jul 17, 2026.
Open?$2.33
High?$2.47
Low?$2.31
Prev. Close?$2.34
Volume?381.2K
Avg. Volume?557.1K
VWAP?$2.38
Rel. Volume?0.68x
Bid / Ask
Bid?$2.30 × 200
Ask?$2.58 × 7.4K
Spread?$0.28
Midpoint?$2.44
Valuation & Ratios
Market Cap?149.9M
Shares Out?63.0M
Float?56.5M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?3.52
EPS?-$1.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Employees
64
Market Cap
147.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-09-03
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200
SAN DIEGO, CA 92130
Phone: 858-727-1040
SAN DIEGO, CA 92130
Phone: 858-727-1040
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.52Distress
Confidence?50%Low
Short InterestLow
Short % of Float?2.35%Low
Short Interest?1.3M
Days to Cover?2.1
Free Float56.5M
Avg Daily Volume627.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?3.23Strong
Quick Ratio?3.23Strong
Cash Ratio?2.70Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.52FAIR▾
Peers100
S&P49
P/S?643.15HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?445.58HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-152.3%WEAK▾
S&P3
ROA?-108.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-57605000
Enterprise Value?$103.8M
Fundamentals ratios updated end of day